Reactive electrophilic species and reactive carbonyls (RES/RCS)

Reactive electrophilic species (RES) and reactive carbonyl species (RCS) are highly reactive small molecules, including aldehydes like 4-hydroxynonenal (4-HNE) and methylglyoxal, that arise from lipid peroxidation and glucose metabolism [1]. These species possess electron-deficient centers that readily form covalent adducts with nucleophilic groups on proteins, DNA, and phospholipids, leading to a state known as "carbonyl stress" [2]. This damage results in protein cross-linking, enzyme inactivation, and the accumulation of advanced glycation end-products (AGEs), which are hallmarks of aging and chronic disease [3]. RES and RCS are heavily implicated in the pathogenesis of diabetic complications, neurodegenerative diseases such as Alzheimer's and Parkinson's, and atherosclerosis [4]. Therapeutic targeting of these species involves the use of "scavengers"—nucleophilic drugs like hydralazine, carnosine, or aminoguanidine—that chemically neutralize the reactive molecules before they can damage cellular components [5]. While effective in preclinical models, the clinical challenge remains achieving high specificity to avoid interfering with essential physiological signaling mediated by certain reactive species [6].

Other names

Reactive carbonyl speciesElectrophilic stress agentsCarbonyl stressLipid peroxidation productsAdvanced glycation end-product precursors

Chemical scavenging and covalent sequestration of reactive electrophilic/carbonyl centers [5].